Wrist magnets, copper bracelets 'ineffective' in relieving arthritis painOctober 17th, 2009 WASHINGTON - Copper bracelets and magnetic wristbands are ineffective in relieving the crippling pain of arthritis, experts have claimed. Pain sufferers have long believed in the healing powers of the devices with some wearers thinking the bands will help ward off the degenerative disease in their advancing years.
FDA rejects labeling claims on vitamin C-enhanced version of Vicks NyquilOctober 14th, 2009 FDA warns P&G for adding vitamin C to NyquilWASHINGTON — Federal drug regulators are scolding Procter & Gamble for adding Vitamin C to its Vicks cold formulas, a combination not allowed by federal regulations. The Food and Drug Administration issued a warning to the consumer products company, saying medications like Vicks Nyquil and Dayquil have not been approved to contain vitamin C.
Recession cuts Johnson & Johnson drug, devices and consumer products sales, profit edges upOctober 13th, 2009 J&J ekes out profit rise despite sales dropTRENTON, N.J. — Band-Aid maker Johnson & Johnson is feeling the pain as consumers worldwide buy more generic health products — whether it's prescription medicines or store-brand bandages — or just do without for as long as they can.
Drug, device maker Johnson & Johnson posts 1 percent rise in 3Q profit despite lower salesOctober 13th, 2009 J&J posts 1 percent profit rise despite sales dropTRENTON, N.J. — Johnson & Johnson on Tuesday reported a meager 1 percent increase in third-quarter profit, as intensifying generic competition slashed sales of blockbuster prescription drugs.
Onyx will acquire Proteolix and its blood cancer drug candidate in deal worth up to $851MOctober 12th, 2009 Onyx Pharma will pay up to $851M for ProteolixNEW YORK — Onyx Pharmaceuticals Inc. said Monday it will buy cancer drug developer Proteolix Inc.
Squatting, sitting cross-legged can worsen arthritis (Oct 12 is World Arthritis Day)October 11th, 2009 NEW DELHI - Seema Rathore, 42, a spirited housewife ignored her paining knee joints for many months. Finally when she visited a doctor she was told she had severe osteoarthritis and would need surgery.
FDA panel favors expanded approval for Pfizer HIV drug as an initial treatmentOctober 8th, 2009 FDA panel backs expanded use of Pfizer HIV drugADELPHI, Md. — Federal health advisers said Thursday that Pfizer's HIV drug Selzentry should be approved for use by patients who have not already taken other drugs to combat the virus.
FDA says Pfizer's pill Selzentry appears safe for broader use against HIVOctober 6th, 2009 FDA sees no safety issues with Pfizer HIV drugWASHINGTON — The Food and Drug Administration said Tuesday an HIV drug from Pfizer appears safe for expanded use in patients who have not already taken other drugs to combat the virus. However, the FDA said Pfizer studies paint a mixed picture of its drug's effectiveness.
Chronic rhinosinusitis patients prone to other chronic illnesses tooOctober 5th, 2009 WASHINGTON - Patients of chronic rhinosinusitis (CRS) are also prone to suffer from other chronic illnesses like asthma, hypertension and arthritis, according to a study. The study used the electronic records of 1,970,695 patients to determine whether there was a relationship between CRS and other chronic conditions.
Bipartisan talks may continue beyond Sept. 15 deadline for Senate Finance proposalSeptember 14th, 2009 Near deadline, health care negotiators pare costsWASHINGTON — Senate health care negotiators say they have cut the cost of their 10-year coverage plan to under $880 billion. But they're not shaking hands yet on a bipartisan deal.
New WHO data sheds light on two leading causes of pneumoniaSeptember 12th, 2009 LONDON - New World Health Organization data has highlighted two leading causes of pneumonia, which claims the highest number of lives of children under age 5, both globally and within developing countries like India, Pakistan and Kenya. The findings could serve as a clarion call to developing country governments to invest in pneumonia prevention programs.
Nanoparticle-laser combo may help deliver drugs into cancer cellsSeptember 11th, 2009 WASHINGTON - Researchers at University of California, Santa Barbara (UCSB) have developed a new way to deliver drugs into cancer cells by exposing them briefly to nanoparticles and lasers. Norbert Reich, senior author and a professor in the Department of Chemistry and Biochemistry at UCSB, conducted the study using cancer cells in mice.
ZymoGenetics says Atacicept did not meet goals for advancing directly to late-stage testingSeptember 10th, 2009 ZymoGenetics says RA drug misses advancement goalsSEATTLE — ZymoGenetics Inc. said Thursday that its drug candidate Atacicept did not meet goals that would have automatically advanced it to late-stage clinical testing as a treatment for rheumatoid arthritis.
Doctor: Mass. Gov. Patrick OK after hip replacement surgery for arthritis, pre-existing injurySeptember 1st, 2009 Gov. Patrick OK after hip replacement surgeryBOSTON — Massachusetts Gov. Deval (deh-VAHL') Patrick is resting comfortably after undergoing hip replacement surgery to alleviate pain from arthritis and an injury he sustained three decades ago.
Gene behind gum disease, osteoporosis, arthritis identifiedAugust 31st, 2009 WASHINGTON - An international team of researchers have identified a gene that is common in the development of gum disease, rheumatoid arthritis, and osteoporosis. Experts at Hospital for Special Surgery say that their findings about the gene, called interferon regulator factor-8 (IRF-8), may lead to new treatments in future.
